Sector : Pharmaceuticals
BSE
339.25 -0.88%
NSE
339.25 -0.93 %
Mar 18, 15:45
Mar 12, 12:34
Cadila Healthcare rises 3% on USFDA approval for drugs to treat high blood pressure
Feb 27, 15:28
Feb 18, 14:14
Accumulate Cadila Healthcare; target of Rs 362: Prabhudas Lilladher
Mar 18, 16:00
Price
BSE
339.25 -0.88%
NSE
339.25 -0.93%
Share Target
Target(Rs)
Tip Period
Stop Loss
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
